Business and Technology Updates
Today is again a mostly business sort of news day. The Biotechnology Industry Organization has issued a press release
about its upcoming April convention in Chicago, which will include 8 panels on the business, science, and regulatory aspects of stem cell research and regenerative medicine. The release goes on to describe the panels in specifics. Some of them look pretty interesting (for example, “Stem Cell Research in Europe: How Do Industry and Academia Collaborate? This session will feature leading speakers from the EC health research funding program, research institutes and companies, who will present their initiatives and discuss requirements for supporting stem cell research”), and I hope that proceedings are made available to the public after the convention.
Cytori Therapeutics, which focuses on deriving stem cells from adipose tissue (fat), received the go-ahead from European regulators to sell its stem cell processing device, according to an AP story on MSN Money
. The press release from Cytori is on Genetic Engineering News
. The device, called the Celution ™ System, can derive stem cells from fat in approximately one hour.
The cord blood bank StemCyte issued a press release
saying that it had recently contributed its 250th cord blood stem cell unit for transplant. The company is based in California and provides blood for transplants internationally. The press release focuses on the work they have been doing for patients with thalassemia, a blood disease similar to sickle-cell anemia.